Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods

Simple item page
dc.contributor.authorLi, Hongzhao
dc.contributor.authorSmith, Greg
dc.contributor.authorGoolia, Melissa
dc.contributor.authorMarszal, Peter
dc.contributor.authorPickering, Bradley S.
dc.date.accessioned2023-07-10T19:27:51Z
dc.date.available2023-07-10T19:27:51Z
dc.date.issued2023-06-19
dc.date.updated2023-06-27T20:19:25Z
dc.description.abstractAbstract Crimean-Congo hemorrhagic fever orthonairovirus (CCHFV) is a biosafety level 4 and World Health Organization top priority pathogen. Infection leads to an often fatal hemorrhagic fever disease in humans. The tick-borne virus is endemic in countries across Asia, Europe and Africa, with signs of spreading into new regions. Despite the severity of disease and the potential of CCHFV geographic expansion to cause widespread outbreaks, no approved vaccine or treatment is currently available. Critical for basic research and the development of diagnostics or medical countermeasures, CCHFV viral stocks are commonly produced in Vero E6 and SW-13 cell lines. While a variety of in-house methods are being used across different laboratories, there has been no clear, specific consensus on a standard, optimal system for CCHFV growth and titration. In this study, we perform a systematic, side-by-side characterization of Vero E6 and SW-13 cell lines concerning the replication kinetics of CCHFV under different culture conditions. SW-13 cells are typically cultured in a CO2-free condition (SW-13 CO2−) according to the American Type Culture Collection. However, we identify a CO2-compatible culture condition (SW-13 CO2+) that demonstrates the highest viral load (RNA concentration) and titer (infectious virus concentration) in the culture supernatants, in comparison to SW-13 CO2− and Vero E6 cultures. This optimal viral propagation system also leads to the development of two titration methods: an immunostaining-based plaque assay using a commercial CCHFV antibody and a colorimetric readout, and an antibody staining-free, cytopathic effect-based median tissue culture infectious dose assay using a simple excel calculator. These are anticipated to serve as a basis for a reproducible, standardized and user-friendly platform for CCHFV propagation and titration.
dc.identifier.citationVirology Journal. 2023 Jun 19;20(1):128
dc.identifier.doi10.1186/s12985-023-02089-w
dc.identifier.urihttps://doi.org/10.1186/s12985-023-02089-w
dc.identifier.urihttp://hdl.handle.net/1993/37412
dc.language.isoeng
dc.language.rfc3066en
dc.publisherBioMed Central (BMC)
dc.rightsopen accessen_US
dc.rights.holderCrown
dc.subjectCrimean-Congo hemorrhagic fever virus
dc.subjectCell line
dc.subjectCell culture
dc.subjectTitration
dc.subjectSW-13
dc.subjectVero E6
dc.subjectHuH-7
dc.subjectBSR-T7/5
dc.subjectPlaque assay
dc.subjectTCID50
dc.titleComparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods
dc.typeJournal Article
local.author.affiliationRady Faculty of Health Sciences::Max Rady College of Medicine::Department of Medical Microbiology and Infectious Diseases
oaire.citation.titleVirology Journal
oaire.citation.volume20
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal article
Size:
2.8 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
770 B
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works